首页> 外文期刊>Cancer biology & therapy >Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells
【24h】

Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells

机译:β2-微球蛋白调节淀粉样蛋白前体样蛋白2表达和胰腺癌细胞的迁移

获取原文
获取原文并翻译 | 示例
           

摘要

Beta 2-microglobulin ((2)m) is a component of the major histocompatibility complex (MHC) class I molecule, which presents tumor antigens to T lymphocytes to trigger cancer cell destruction. Notably, (2)m has been reported as persistently expressed, rather than down regulated, in some tumor types. For renal cell and oral squamous cell carcinomas, (2)m expression has been linked to increased migratory capabilities. The migratory ability of pancreatic cancer cells contributes to their metastatic tendencies and lethal nature. Therefore, in this study, we examined the impact of (2)m on pancreatic cancer cell migration. We found that (2)m protein is amply expressed in several human pancreatic cancer cell lines (S2-013, PANC-1, and MIA PaCa-2). Reducing (2)m expression by short interfering RNA (siRNA) transfection significantly slowed the migration of the PANC-1 and S2-013 cancer cell lines, but increased the migration of the MIA PaCa-2 cell line. The amyloid precursor-like protein 2 (APLP2) has been documented as contributing to pancreatic cancer cell migration, invasiveness, and metastasis. We have previously shown that (2)m/HLA class I/peptide complexes associate with APLP2 in S2-013 cells, and in this study we also detected their association in PANC-1 cells but not MIA PaCa-2 cells. In addition, siRNA down regulation of (2)m expression diminished the expression of APLP2 in S2-013 and PANC-1 but heightened the level of APLP2 in MIA PaCa-2 cells, consistent with our migration data and co-immunoprecipitation data. Thus, our findings indicate that (2)m regulates pancreatic cancer cell migration, and furthermore suggest that APLP2 is an intermediary in this process.
机译:β2-微球蛋白((2)M)是主要组织相容性复合物(MHC)I类分子的组分,其呈现肿瘤抗原对T淋巴细胞以引发癌细胞破坏。值得注意的是,在一些肿瘤类型中,(2)M已被报告为持续表达而不是下调。对于肾细胞和口腔鳞状细胞癌,(2)M表达已与增加的迁移能力有关。胰腺癌细胞的迁移能力有助于转移倾向和致命性。因此,在本研究中,我们研究了(2)M对胰腺癌细胞迁移的影响。我们发现(2)蛋白在几种人类胰腺癌细胞系中表达(S2-013,Panc-1和Mia Paca-2)。通过短干扰RNA(siRNA)转染减少(2)M表达显着减慢了Panc-1和S2-013癌细胞系的迁移,但增加了MIA Paca-2细胞系的迁移。淀粉样蛋白前体样蛋白2(APLP2)被记录为胰腺癌细胞迁移,侵袭性和转移。我们之前已经表明(2)M / HLA类I /肽复合物在S2-013细胞中与APLP2相关联,并且在该研究中,我们还发现了它们在PANC-1细胞中的关联而不是MIA PACA-2细胞。此外,(2)M表达的siRNA调节减少了S2-013和PANC-1中APLP2的表达,但是加强了MIA PACA-2细胞中APLP2的水平,与我们的迁移数据和共免疫沉淀数据一致。因此,我们的研究结果表明(2)M调节胰腺癌细胞迁移,此外表明APLP2是该过程中的中介。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号